GeneDx Holdings (WGS) Change in Inventory (2020 - 2026)

GeneDx Holdings (WGS) has reported Change in Inventory for 7 consecutive years, with $5.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Inventory rose 1001.59% year-over-year to $5.7 million in Q2 2026; TTM through Jun 2026 was $6.0 million, a 157.17% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 32.92% from the prior year.
• Change in Inventory was $5.7 million for Q2 2026 at GeneDx Holdings, up from -$1.7 million in the prior quarter.
• Over five years, Change in Inventory peaked at $5.7 million in Q2 2026 and troughed at -$7.6 million in Q4 2022.
• A 5-year average of $370500.0 and a median of $80500.0 in 2023 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory tumbled 379.25% in 2025 and surged 1001.59% in 2026, its largest moves.
• Over 5 years, Change in Inventory stood at -$7.6 million in 2022, then jumped by 96.14% to -$293000.0 in 2023, then jumped by 254.95% to $454000.0 in 2024, then surged by 640.97% to $3.4 million in 2025, then soared by 68.31% to $5.7 million in 2026.
• The last three Change in Inventory figures came in at $5.7 million (Q2 2026), -$1.7 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.